MAPT and Huntington disease: To determine if peripheral tau may be a useful biomarker of cognitive dysfunction in HD, we collected blood samples and clinical data from HD gene carriers and age-/gender-matched healthy controls (CTRL) at three locations in Canada and in the UK.